How shorted is CELYAD ONCOLOGY? BE0974260896
0.65%
of share capital in disclosed short positions · 15 Oct 2021
- 5-day change
- −0.08
- 20-day change
- –
Who is short CELYAD ONCOLOGY?
No individual positions of 0.5% or more are currently disclosed.
Named positions of 0.5%+ as published by the FSMA. The dates shown are each holder's latest disclosure date.
Sector: Healthcare
History
| Position date | Short % | Change |
|---|---|---|
| 15 Oct 2021 | 0.65% | 0.00 |
| 14 Oct 2021 | 0.65% | 0.00 |
| 13 Oct 2021 | 0.65% | 0.00 |
| 12 Oct 2021 | 0.65% | 0.00 |
| 11 Oct 2021 | 0.65% | −0.08 |
| 8 Oct 2021 | 0.73% | – |
About this data
- ISIN
- BE0974260896
- Regulator
- FSMA (Belgium)
- First seen in dataset
- 8 Oct 2021
We show regulatory short-position data only: no prices, no valuations, no recommendations.
Frequently asked questions
- How shorted is CELYAD ONCOLOGY right now?
- Disclosed net short positions total 0.65% of CELYAD ONCOLOGY's share capital as of 15 Oct 2021, per the FSMA's public register.
- Who is shorting CELYAD ONCOLOGY?
- No individual positions of 0.5% or more are currently disclosed for CELYAD ONCOLOGY.
- What is CELYAD ONCOLOGY's short interest?
- 0.65% of share capital as of 15 Oct 2021. "Short interest" is the US term; the FSMA publishes each disclosed net short position of 0.5% or more by name, summed here, so it is a lower bound on all short selling in the stock.
- What does this number include?
- The sum of individually disclosed net short positions of 0.5% or more of share capital. Positions between 0.1% and 0.5% are reported to the regulator privately and are not public, so the true total can be higher.
- How often is this updated?
- Position holders must disclose changes by the next trading day; we refresh from the FSMA's register every trading day.